|
Competition from Constellation
|
4
|
Zenith Epigenetics
|
Dec 13, 2017 09:01AM
|
|
Beacon report spreading
|
7
|
Resverlogix Corp.
|
Dec 07, 2017 08:06PM
|
|
Zenith new VP
|
2
|
Zenith Epigenetics
|
Dec 07, 2017 03:04PM
|
|
Dr Nichols still loves Esperion
|
1
|
Resverlogix Corp.
|
Oct 11, 2017 03:20PM
|
|
Re: Explanation?
|
5
|
Resverlogix Corp.
|
Oct 05, 2017 07:55PM
|
|
Re: BET inhibitor and BRD4 papers keep piling up
|
7
|
Resverlogix Corp.
|
Sep 24, 2017 04:41PM
|
|
Trading volumes
|
4
|
Resverlogix Corp.
|
Sep 12, 2017 02:26PM
|
|
Re: Value
|
2
|
Zenith Epigenetics
|
Aug 19, 2017 04:06PM
|
|
Re: Zenith new VP
|
3
|
Zenith Epigenetics
|
Jul 29, 2017 06:48PM
|
|
New compound - ApaBearDownAzone
|
9
|
Resverlogix Corp.
|
Jun 01, 2017 03:10PM
|
|
Analyst Rating Change Notice
|
3
|
Resverlogix Corp.
|
Jan 09, 2017 08:45AM
|
|
Pfizer and Astellas Announce Top-Line Results from Phase 4 PLATO Trial of XTANDI® (enzalutamide)
|
4
|
Zenith Epigenetics
|
Dec 14, 2016 04:34PM
|
|
Pfizer's PCSK9 Inhibitor bococizumab - further development being scrapped
|
5
|
Resverlogix Corp.
|
Nov 01, 2016 11:17AM
|
|
Re: date and time
|
2
|
Resverlogix Corp.
|
Oct 22, 2016 02:02PM
|
|
Re: Zenith AGM Dec 15
|
4
|
Zenith Epigenetics
|
Oct 17, 2016 08:00PM
|
|
Re: Resverlogix Announces Annual and Special Meeting of Shareholders
|
6
|
Resverlogix Corp.
|
Oct 07, 2016 10:19AM
|
|
Another reason for Zenith to get busy with a Nasdaq listing
|
4
|
Zenith Epigenetics
|
Oct 03, 2016 12:47PM
|
|
Nice background article on mCRPC
|
5
|
Zenith Epigenetics
|
Oct 02, 2016 08:29PM
|
|
Re: When in Rome.......ESC presentations from August now online
|
6
|
Resverlogix Corp.
|
Sep 26, 2016 09:36AM
|
|
Re: Sometimes 1 + 1 = 3
|
9
|
Resverlogix Corp.
|
Sep 24, 2016 05:00PM
|
